←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS43%
R&D + SG&A11%
Op Margin46%
FINANCIAL HEALTH
REVENUE
$27.7B
Growth
4%
Gross M.
57%
P/E
21.7
EV/EBITDA
16.3
Net M.
32%
FCF M.
23%
D/E
3.4
Op M.
46%
PLUG INTO YOUR DCF
Historical growth
7%
Analyst 5y growth
—
Forward P/E
19.1
PEG ratio
2.50
Trailing EPS
$12.30
Forward EPS
$14.00
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
MEDTrading above a mechanical base-case DCF estimate of $233.83 (default assumptions) — priced for continued strong execution.
HIGDebt/equity of 3.40 — elevated leverage, sensitive to rate/refinancing risk.
LOWRevenue growing 4% YoY — steady, unspectacular growth.
🐂 BULL
MCD shows revenue grew +3.7% YoY, 46% operating margin, a healthy 23% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 21.7 and EV/EBITDA of 16.3, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.